![](/imager/uploads/Companies/Chemify/40915/20230309_Z6_21793_6439e647a38ed5b4d852739476ebaac9.webp)
![](/uploads/logos/_logo_h/chemify_logo_wmohln-black.jpg)
Robotic synthesis of chemicals is a burgeoning technology, but there’s no standard operating system or specification language to make the process interoperable across different labs or facilities. Chemify founder and CEO Lee Cronin developed XDL, a chemical description language intended to be to the next generation of synthetic chemistry machines what HTML is to a web browser. Chemify is building automated synthesis hardware that uses XDL to convert code to molecules, or molecules to code, on demand.
In The Media
Explore Companies
![](/imager/uploads/logos/58681/Avicenna_logo_black_117378e58441a39758ec294c229f7090.webp)
Avicenna Biosciences
Using AI to speed through the last mile of drug discovery
![](/imager/uploads/logos/58643/latus-logo-copy_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Latus/58650/Latus-lab_6439e647a38ed5b4d852739476ebaac9.webp)
Latus Bio
Finding precisely tuned viral vectors for gene therapy in CNS disorders
![](/imager/uploads/logos/57002/radionetics-logo_black_117378e58441a39758ec294c229f7090.webp)
![](/imager/uploads/Companies/Radionetics/57003/Radionetics_6439e647a38ed5b4d852739476ebaac9.webp)
Radionetics Oncology
Discovering more precise ways to deploy radiopharmaceuticals against solid tumors
![](/imager/uploads/logos/55895/DVLP-logo-black_117378e58441a39758ec294c229f7090.webp)
DVLP Medicines
Creating a software co-pilot for drug development and a new marketplace for investors and outsourced R&D and manufacturing